Mengqi Song

Qingdao University

Papers

2

Total Citations

38

H-Index

2

About

Dr. Mengqi Song is a pioneering surgeon at the forefront of robotic and tele-surgical innovation, with a primary focus on urologic oncology and minimally invasive surgery. Dr. Song’s most impactful contribution is the landmark 2022 study demonstrating the first successful application of 5G technology to conduct a tele-surgical robot-assisted laparoscopic radical cystectomy, performed over a network distance of nearly 3,000 kilometers. This groundbreaking work, cited 34 times, proved the effectiveness, safety, and stability of ultra-remote surgery, opening new frontiers for global access to specialized care. Further solidifying their expertise, Dr. Song’s 2024 single-center experience with the Da Vinci Surgical System in 105 retroperitoneal tumor resections provides crucial clinical evidence for expanding robotic applications beyond common abdominal procedures. By validating both the extreme reach of telesurgery and the routine precision of robotic resection, Dr. Song is shaping the future of surgical practice, demonstrating that distance is no longer a barrier to expert intervention.

Research Focus

Key Achievements

2
H-Index
2
Papers
38
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Application of 5G technology to conduct tele‐surgical robot‐assisted laparoscopic radical cystectomy
34 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 44
🏛 Institutions: Qingdao University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago